Literature DB >> 2984705

Effects of nicotine on beta-endorphin, alpha MSH, and ACTH secretion by isolated perfused mouse brains and pituitary glands, in vitro.

M A Marty, V G Erwin, K Cornell, J M Zgombick.   

Abstract

The effects of nicotine on secretion of the pituitary peptides beta-endorphin, alpha MSH, and ACTH were studied using the isolated perfused mouse brain (IPMB) and isolated superfused pituitaries of C3H mice. Nicotine (6.1 microM) stimulated secretion of beta-endorphin immunoreactivity from C3H IPMB approximately twofold. Secretion of alpha MSH immunoreactivity was stimulated approximately two- and sixfold by 6.1 microM and 12.2 microM nicotine, respectively. However, nicotine (6.1 microM) had no direct effect on the secretion of beta-endorphin, alpha MSH, or ACTH immunoreactivities from the isolated superfused pituitaries. The data suggest nicotine acts in the brain to stimulate pituitary secretion of alpha MSH and beta-endorphin. Electrocorticographic (ECoG) activity of the IPMB was monitored. Nicotine induced characteristic ECoG changes including a reduction of input voltage, a biphasic response of rapid desynchronization followed by prolonged synchronization, and seizure at high doses (12.2 microM).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984705     DOI: 10.1016/0091-3057(85)90397-1

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  12 in total

1.  Stress-induced activation of the dynorphin/κ-opioid receptor system in the amygdala potentiates nicotine conditioned place preference.

Authors:  Jeffrey S Smith; Abigail G Schindler; Emma Martinelli; Richard M Gustin; Michael R Bruchas; Charles Chavkin
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

2.  μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief.

Authors:  Mary Falcone; Allison B Gold; E Paul Wileyto; Riju Ray; Kosha Ruparel; Andrew Newberg; Jacob Dubroff; Jean Logan; Jon-Kar Zubieta; Julie A Blendy; Caryn Lerman
Journal:  Psychopharmacology (Berl)       Date:  2012-03-03       Impact factor: 4.530

Review 3.  Regulation of feeding-associated peptides and receptors by nicotine.

Authors:  M D Li; S L Parker; J K Kane
Journal:  Mol Neurobiol       Date:  2000 Aug-Dec       Impact factor: 5.590

4.  Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers.

Authors:  Daniel J O Roche; Lara A Ray; Megan M Yardley; Andrea C King
Journal:  Curr Addict Rep       Date:  2016-02-03

5.  Acute stress or corticosterone administration reduces responsiveness to nicotine: implications for a mechanism of conditioned tolerance.

Authors:  A R Caggiula; L H Epstein; S M Antelman; S Saylor; S Knopf; K A Perkins; R Stiller
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse.

Authors:  K J Jackson; Frank Ivy Carroll; S S Negus; M I Damaj
Journal:  Psychopharmacology (Berl)       Date:  2010-03-16       Impact factor: 4.530

Review 7.  Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.

Authors:  Fernando Berrendero; Patricia Robledo; José Manuel Trigo; Elena Martín-García; Rafael Maldonado
Journal:  Neurosci Biobehav Rev       Date:  2010-02-16       Impact factor: 8.989

8.  Activation of the opioid μ1, but not δ or κ, receptors is required for nicotine reinforcement in a rat model of drug self-administration.

Authors:  Xiu Liu; Courtney Jernigan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-10-20       Impact factor: 5.067

9.  Dexamethasone attenuation of the cortisol response to nicotine in smokers.

Authors:  O F Pomerleau; C S Pomerleau
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

10.  Nicotine anxiogenic and rewarding effects are decreased in mice lacking beta-endorphin.

Authors:  José M Trigo; Andreas Zimmer; Rafael Maldonado
Journal:  Neuropharmacology       Date:  2009-04-17       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.